Completed PHASE2 INTERVENTIONAL NCT00180856

Radiofrequency Ablation of Lung Tumors

A Phase II Study of Radiofrequency Ablation of Lung Tumors

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Updated 4 times since 2017 Last updated: Sep 11, 2005 Started: Jan 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lung Cancer and Metastasis, this trial is completed. The trial is conducted by Gustave Roussy, Cancer Campus, Grand Paris and has accumulated 4 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gustave Roussy, Cancer Campus, Grand Paris

Data source: Gustave Roussy, Cancer Campus, Grand Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France
• Villejuif, France